UK announces full inquiry into medicines shortages
This article was originally published in SRA
UK medicine shortages of brand name prescription drugs, which the pharmaceutical industry has attributed to parallel trade, are to be the subject of a major inquiry, says the All-Party Pharmacy Group, made up of members of the House of Commons and the House of Lords from various political parties1.
You may also be interested in...
Brazil’s medicines regulator, ANVISA, finally has a new set of rules for the evaluation and marketing authorization of advanced therapy medicines.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.